Shanghai, China

Yunfu Luo

USPTO Granted Patents = 33 

 

 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
33 patents (USPTO):

Title: The Innovative Mind of Yunfu Luo: Pioneering Patents in Pharmaceutical Research

Introduction: Yunfu Luo, based in Shanghai, China, is a prominent inventor with a remarkable portfolio of 30 patents. His work primarily focuses on developing innovative solutions for pharmaceutical applications, particularly in the treatment of chronic diseases.

Latest Patents: Among his most recent inventions are two significant patents: firstly, a fused tri-cyclic compound designed to act as a dual inhibitor for PDE3 and PDE4. This compound has implications in the preparation of drugs aimed at treating PDE3/PDE4 associated diseases, especially chronic obstructive pulmonary disease (COPD). The patent details a specific compound formula and its pharmaceutically acceptable salts. Secondly, he has developed a bicyclic compound that serves as a CRBN protein regulator, which is crucial in preparing medications for conditions related to the CRBN receptor. The patent outlines the compound formula and its potential therapeutic applications.

Career Highlights: Throughout his career, Yunfu has made significant contributions to the pharmaceutical industry. He has been affiliated with major corporations such as Merck Sharp & Dohme Corporation and Medshine Discovery Inc., where he utilized his skills to push the boundaries of medicinal chemistry and drug development.

Collaborations: Yunfu has collaborated with notable professionals in his field, including Nigel J. Liverton and Scott D. Kuduk. These partnerships have enhanced his research efforts and contributed to his success in securing multiple patents.

Conclusion: Yunfu Luo's inventive contributions to the pharmaceutical sector reflect his commitment to solving complex health issues through innovative research. With a strong patent portfolio and valuable collaborations, he continues to influence the landscape of medicine and improve therapeutic options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…